Precision blood tests.
Radically affordable.
Always reliable.
Breakthrough biomarker quantification technology that combines precision, affordability, and accessibility. Empowering researchers and clinicians to advance personalized medicine and improve patient outcomes.
Leading the Future of Medicine
Pareon Biosystems has developed a breakthrough biomarker quantification method that addresses critical limitations in existing multiplex technologies. Our solution combines precision, affordability, and accessibility to enable widespread adoption of personalized medicine in both research and clinical settings.
Technology Development & Applications
Our core biomarker quantification platform is being developed for multiple applications across research and clinical settings.
Our Team
Led by world-renowned experts in genetics, data science, business development, and technical innovation.
Professor & University Scholar at McMaster University, renowned for pioneering work in cardiovascular and cerebrovascular disease genetics. Leading expert in precision medicine and biomarker research.
Global Recognition
Research Impact
- > 350 peer-reviewed publications
- > 50,000 citations and h-index > 100 (Google Scholar)
Global Rankings
- #313 globally (top 0.2%) in laboratory medicine (ScholarGPS; last 5 years)
- #27 globally in biomarker research (ScholarGPS; last 5 years)
Leadership Roles
- Director of Clinical Research Laboratory & Biobank - Genetic & Molecular Epidemiology Laboratory
- Royal Society of Canada Fellow (2018)
Dr. Wei Deng
Ph.D.
Data Scientist
Assistant Professor, McMaster
Dr. Michael Kamal
Ph.D.
Business Development
MBI Candidate
Nathan Cawte
B. Tech.
Technical Specialist
Get in Touch
Interested in partnering with us or learning more about our research? We'd love to hear from you.